DEREGULATED EXPRESSION OF THE C-MYC ONCOGENE ABOLISHES INHIBITION OF PROLIFERATION OF RAT VASCULAR SMOOTH-MUSCLE CELLS BY SERUM REDUCTION, INTERFERON-GAMMA, HEPARIN, AND CYCLIC-NUCLEOTIDE ANALOGS AND INDUCES APOPTOSIS

被引:200
作者
BENNETT, MR
EVAN, GI
NEWBY, AC
机构
[1] UNIV WALES COLL MED, DEPT CARDIOL, CARDIFF, S GLAM, WALES
[2] IMPERIAL CANC RES FUND, CELL NULEUS LAB, LONDON, ENGLAND
关键词
C-MYC; RETROVIRUS; VASCULAR SMOOTH; MUSCLE CELLS; APOPTOSIS;
D O I
10.1161/01.RES.74.3.525
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
We have investigated the requirement for c-myc downregulation in the growth arrest of vascular smooth muscle cells (VSMCs). Rat VSMCs were infected with a retrovirus vector directing constitutive expression of either the complete human c-Myc protein (VSM-myc cells) or the c-Myc deletion mutant D106-143, which is inactive in cotransformation and autosuppression assays (VSM-D106-143 myc cells). Clones of transfected VSM-myc cells were isolated that constitutively expressed a range of levels of c-Myc protein from that observed in normal proliferating VSMCs to approximately seven times normal. The growth rates of these clones and their responses to growth inhibitors were then assessed. VSM-myc clones possessed a shorter mean intermitotic time than normal cells, which was inversely correlated (P<.05) with the level of c-Myc protein expressed. VSM-myc cells also expressed lower levels of cr-smooth muscle actin mRNA and protein and exhibited an altered morphology. The proliferation of normal VSMCs and VSM-D106-143 myc cells was inhibited by serum reduction (0.5% fetal calf serum) and also by treatment with interferon-gamma (100 IU/mL), heparin (50 mu g/mL), 8-bromo-cAMP (0.1 mmol/L), or 8-bromo-cGMP (0.1 mmol/L). In contrast, proliferation of VSM-myc cells was not inhibited by any of these agents, even if present at 10-fold higher concentrations. However, approximate to 75% of VSM-myc cells expressing levels of c-Myc protein seen in normal proliferating VSMCs underwent apoptosis after 4 days of serum reduction or treatment with interferon-gamma. The results show that constitutive c-myc expression induces continuous cell proliferation, reduction in cr-smooth muscle actin expression and apoptosis in VSMCs. We conclude that downregulation of c-myc is a prerequisite for growth arrest and subsequent survival of VSMCs. Conversely, deregulated c-myc expression may be important in the proliferation and death of VSMCs-characteristics of the pathogenesis of atherosclerosis. (Circ Res. 1994;74:525-536.)
引用
收藏
页码:525 / 536
页数:12
相关论文
共 58 条
[1]
ONCOGENIC ACTIVITY OF THE C-MYC PROTEIN REQUIRES DIMERIZATION WITH MAX [J].
AMATI, B ;
BROOKS, MW ;
LEVY, N ;
LITTLEWOOD, TD ;
EVAN, GI ;
LAND, H .
CELL, 1993, 72 (02) :233-245
[2]
TRANSCRIPTIONAL ACTIVATION BY THE HUMAN C-MYC ONCOPROTEIN IN YEAST REQUIRES INTERACTION WITH MAX [J].
AMATI, B ;
DALTON, S ;
BROOKS, MW ;
LITTLEWOOD, TD ;
EVAN, GI ;
LAND, H .
NATURE, 1992, 359 (6394) :423-426
[3]
AMATI B, IN PRESS EMBO J
[4]
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[5]
ASKEW DS, 1991, ONCOGENE, V6, P1915
[6]
PROTOONCOGENE EXPRESSION IN RABBIT AORTA AFTER WALL INJURY 1ST MARKER OF THE CELLULAR PROCESS LEADING TO RESTENOSIS AFTER ANGIOPLASTY [J].
BAUTERS, C ;
DEGROOTE, P ;
ADAMANTIDIS, M ;
DELCAYRE, C ;
HAMON, M ;
LABLANCHE, JM ;
BERTRAND, ME ;
DUPUIS, B ;
SWYNGHEDAUW, B .
EUROPEAN HEART JOURNAL, 1992, 13 (04) :556-559
[7]
THE ORNITHINE DECARBOXYLASE GENE IS A TRANSCRIPTIONAL TARGET OF C-MYC [J].
BELLOFERNANDEZ, C ;
PACKHAM, G ;
CLEVELAND, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7804-7808
[8]
BENNETT MR, 1992, EUR HEART J, V13, P228
[9]
CASCADE INDUCTION OF C-FOS, C-MYC, AND HEAT-SHOCK 70K TRANSCRIPTS DURING REGRESSION OF THE RAT VENTRAL PROSTATE-GLAND [J].
BUTTYAN, R ;
ZAKERI, Z ;
LOCKSHIN, R ;
WOLGEMUTH, D .
MOLECULAR ENDOCRINOLOGY, 1988, 2 (07) :650-657
[10]
CELL-CYCLE DEPENDENT GENE-EXPRESSION IN QUIESCENT STIMULATED AND ASYNCHRONOUSLY CYCLING ARTERIAL SMOOTH-MUSCLE CELLS IN CULTURE [J].
CAMPAN, M ;
DESGRANGES, C ;
GADEAU, AP ;
MILLET, D ;
BELLOC, F .
JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 150 (03) :493-500